Eli Lilly is trading 4.3% down at ARS 32,740.00 as managed care margin concerns weigh on the broader healthcare sector.
- The move appears driven by sector-wide sentiment rather than any fresh, company-specific catalysts or major news for Eli Lilly itself.
- The stock is currently underperforming a broadly higher U.S. equity market.